FindTrial
Sign In

Effect of phosphocreatine sodium pretreatment on hepatic function before hepatectomy in hepatic tumor resection

Effect of phosphocreatine sodium pretreatment on hepatic function before hepatectomy in hepatic tumor resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011732
Enrollment
Unknown
Registered
2017-06-21
Start date
2017-06-27
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic dysfunction

Interventions

Low group:Creatine phosphate sodium 2g
High group:Creatine phosphate sodium 2g
control goup:none

Sponsors

Eastern Hepatobiliary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients need resection of liver tumor with ASA I-III.

Exclusion criteria

Exclusion criteria: 1. patients with hypertension, coronary heart disease, arrhythmia, acute and chronic heart failure and so on that affects the heart function; 2. patients paticipating other clinical trail or with other reasons not suitable for clinical trials according to the reseachers.

Design outcomes

Primary

MeasureTime frame
ALT;AST;Endogenous antioxidant enzymes;—

Countries

China

Contacts

Public ContactJinchao Song

Department of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University

sjch2006@sohu.com+86 13167000520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026